Precision Medicine News and Updates | Precision Medicine Online
WEBThe plan, announced in January, would reclassify many Class III in vitro diagnostic devices as Class II, impacting companion diagnostic and infectious disease tests. Precision Medicine Online provides the latest news for healthcare leaders and scientists interested in precision medicine and individualized approaches to treatment and prevention.
Precision Oncology News - Precision Medicine Online
WEBGuardant Health Liquid Biopsy CDx Gets Japanese Regulatory Approval for Janssen Lung Cancer Drug. Aug 30, 2024. Hackensack Meridien Health Launches Cancer Risk, Early Detection Program; Eyes Multi-Cancer Testing. Aug 29, 2024. MOMA Therapeutics Advances Cancer Drugs Interrogating Cell Molecular Machinery Into Clinic. Aug 29, 2024.
Precision Medicine Diagnostics
WEBNextPoint Therapeutics Nominates Third Clinical Program Targeting HHLA2/B7-H7. The firm is hoping to advance NPX372 for treating B7-H7-expressing solid tumors and is developing an assay to identify best responders. Sep 5, 2024.
Disease Research & Diagnostics News | Precision Medicine Online
WEBNews and analysis on disease research and diagnostics from Precision Medicine Online.
Breaking News - Precision Medicine Online
WEB6 days ago · IN8bio to Lay off Nearly Half of Workforce, Narrow Pipeline Focus on AML Cell Therapy. The firm is dropping two glioblastoma programs and cutting 49 percent of its staff to advance its gamma delta T-cell therapy INB-100 in post-transplant AML. Sep 06, 2024.
Price of Precision: Patients, Oncologists Highlight Costs of Fighting ...
WEBJun 1, 2023 · NEW YORK — The side effects of cancer treatments are notoriously arduous, but the market entry of high-priced biomarker-informed drugs and immunotherapies has introduced another type of toxicity to the cancer lexicon — financial toxicity.
Precision Oncology in 2022: New Drugs and Tests Amid Ongoing …
WEBJan 4, 2023 · NEW YORK – Looking back at 2022, plenty of new CAR T-cell, radioligand, and biomarker-defined treatments entered the market, as did new tissue and liquid biopsy tests to identify cancer patients eligible for these therapies.
Genomics Technology, Tools & Methods - Precision Medicine Online
WEBNovartis' Scemblix Bests Gleevec, Second-Generation TKIs in Frontline CML. The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics from Precision Medicine Online.
Regulatory News & FDA Approvals | Precision Medicine Online
WEBFoundation Medicine Nets FDA Approval for Tissue, Liquid NGS CDx for Lynparza Combo. The FDA approved FoundationOne CDx and FoundationOne Liquid for identifying BRCA1/2-mutated mCRPC patients eligible for Lynparza, Zytiga, …
Breaking News - Precision Medicine Online
WEBUnder the agreement, the companies aim to discover new drug targets in cardiovascular and renal diseases using Quotient's cell phenotyping and genomic sequencing platform.